FULCRUM THERAPEUTICS INC's ticker is FULC and the CUSIP is 359616109. A total of 117 filers reported holding FULCRUM THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.07 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $14,560,000 | -7.7% | 2,000,000 | +2.6% | 1.71% | -12.0% |
| Q3 2022 | $15,776,000 | +65.1% | 1,950,000 | 0.0% | 1.94% | +10.6% |
| Q2 2022 | $9,555,000 | -59.6% | 1,950,000 | +95.0% | 1.75% | -42.8% |
| Q1 2022 | $23,650,000 | +95.2% | 1,000,000 | +46.0% | 3.07% | +145.3% |
| Q4 2021 | $12,118,000 | +61.6% | 685,000 | +67.1% | 1.25% | -16.6% |
| Q2 2020 | $7,499,000 | +17.9% | 410,000 | -23.0% | 1.50% | -38.0% |
| Q1 2020 | $6,358,000 | +209.1% | 532,520 | +330.7% | 2.42% | +376.9% |
| Q4 2019 | $2,057,000 | – | 123,635 | – | 0.51% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP III, LLC | 3,962,202 | $19,415,000 | 7.94% |
| TRV GP IV, LLC | 2,343,154 | $11,481,000 | 7.55% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 949 | $193,741,000 | 2.02% |
| Logos Global Management LP | 1,950,000 | $9,555,000 | 1.75% |
| COWEN AND COMPANY, LLC | 2,385,885 | $11,691,000 | 1.13% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 3,355,624 | $16,443,000 | 0.62% |
| ACUTA CAPITAL PARTNERS, LLC | 200,000 | $980,000 | 0.55% |
| RTW INVESTMENTS, LP | 3,961,194 | $19,410,000 | 0.50% |
| Parkman Healthcare Partners LLC | 262,689 | $1,287,000 | 0.47% |
| Deep Track Capital, LP | 1,000,000 | $4,900,000 | 0.32% |